The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors

Hepatology

Volumn 25, Issue 3, 1997, Pages 702-704

  Prati, Daniele ^a   Capelli, Carmen ^a   Silvani, Carla ^a   De Mattei, Claudia ^a   Bosoni, Patrizia ^a   Pappalettera, Marco ^a   Mozzi, Fulvio ^a   Colombo, Massimo ^b   Zanella, Alberto ^a   Sirchia, Girolamo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD DONOR; FEMALE; HEPATITIS C; HUMAN; INCIDENCE; INFECTION RISK; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEROCONVERSION;

ADULT; BLOOD DONORS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEPATITIS C; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031051108     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250335     Document Type: Article

References (11)

1. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
2. Alter MJ, Margolis HS, Krawcynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
3. Aach RD, Stevens CE, Hollinger FB. Hepatitis C virus infection in post-transfusion hepatitis - an analysis with first- and second-generation assays. N Engl J Med 1991;325:1325-1329.
4. Donahue JG, Mun̄oz A, Ness PM, Brown DE, Yawn DH, McAllister HA, Reitz BA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327:369-373.
5. Nelson KE, Donahue JG, Stambolis V. Post-transfusion hepatitis C virus infection (Letter). N Engl J Med 1992;327:1601-1602.
6. Blajchman MA, Bull SB, Feinman SVTI. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Lancet 1995; 345:21-25.
7. Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Lelie PN. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report. Vox Sang 1995;68:55-56.
8. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:169-696.
9. Chiaramonte M, Stroffolini T, Lorenzoni U, Minniti F, Conti S, Floreani A, Ntakirutimana E, et al. Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol 1995; 24:129-133.
10. Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, Zanuso F, et al. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 1996;110-178-183.
11. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JH, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-2235.